JP2025510963A5 - - Google Patents
Info
- Publication number
- JP2025510963A5 JP2025510963A5 JP2024557495A JP2024557495A JP2025510963A5 JP 2025510963 A5 JP2025510963 A5 JP 2025510963A5 JP 2024557495 A JP2024557495 A JP 2024557495A JP 2024557495 A JP2024557495 A JP 2024557495A JP 2025510963 A5 JP2025510963 A5 JP 2025510963A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- patient
- domain
- hypophosphatemic rickets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263325554P | 2022-03-30 | 2022-03-30 | |
| US63/325,554 | 2022-03-30 | ||
| PCT/US2022/077407 WO2023191898A1 (en) | 2022-03-30 | 2022-09-30 | Method and compositions for treatment, amelioration, and/or prevention of diffuse idiopathic skeletal hyperostosis (dish) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510963A JP2025510963A (ja) | 2025-04-15 |
| JP2025510963A5 true JP2025510963A5 (enExample) | 2025-10-06 |
Family
ID=88202983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557495A Pending JP2025510963A (ja) | 2022-03-30 | 2022-09-30 | 広汎性特発性骨増殖症（ｄｉｓｈ）の治療、改善および／または予防のための方法および組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20260041742A1 (enExample) |
| EP (1) | EP4499130A4 (enExample) |
| JP (1) | JP2025510963A (enExample) |
| KR (1) | KR20250047645A (enExample) |
| CN (1) | CN119183382A (enExample) |
| AU (1) | AU2022450370A1 (enExample) |
| CA (1) | CA3246877A1 (enExample) |
| CO (1) | CO2024014833A2 (enExample) |
| IL (1) | IL315907A (enExample) |
| MX (1) | MX2024011876A (enExample) |
| TW (1) | TW202342103A (enExample) |
| WO (1) | WO2023191898A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026102337A1 (en) | 2024-11-08 | 2026-05-15 | Biomarin Pharmaceutical Inc. | Enpp1 for use in the treatment of calciphylaxis |
| CN120163825B (zh) * | 2025-05-20 | 2025-08-08 | 青岛大学 | 一种颈椎后纵韧带骨化症自动定位及分型方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1044468A1 (zh) * | 1998-12-03 | 2002-10-25 | 海斯塔泰克有限责任公司 | 治療哮喘和炎症的小肽和方法 |
| EP1736553A1 (en) * | 2005-06-17 | 2006-12-27 | Centre National De La Recherche Scientifique | ENPP1 (PC-1) gene haplotype associated with the risk of obesity and type 2 diabetes and their applications |
| JP2021523139A (ja) * | 2018-05-08 | 2021-09-02 | イエール ユニバーシティ | 腎石症の進行を遅らせるための組成物および方法 |
| EP3844280A4 (en) * | 2018-08-31 | 2022-09-14 | Yale University | ENPP1 POLYPEPTIDES AND METHODS OF USE |
| US20220195402A1 (en) * | 2019-04-05 | 2022-06-23 | Yale University | Enpp1 polypeptides and methods of using same |
| EP4162036A1 (en) * | 2020-06-09 | 2023-04-12 | Inozyme Pharma, Inc. | Soluble enpp1 or enpp3 proteins and uses thereof |
-
2022
- 2022-09-30 CN CN202280096064.9A patent/CN119183382A/zh active Pending
- 2022-09-30 CA CA3246877A patent/CA3246877A1/en active Pending
- 2022-09-30 EP EP22936031.8A patent/EP4499130A4/en active Pending
- 2022-09-30 IL IL315907A patent/IL315907A/en unknown
- 2022-09-30 JP JP2024557495A patent/JP2025510963A/ja active Pending
- 2022-09-30 TW TW111137435A patent/TW202342103A/zh unknown
- 2022-09-30 KR KR1020247035979A patent/KR20250047645A/ko active Pending
- 2022-09-30 WO PCT/US2022/077407 patent/WO2023191898A1/en not_active Ceased
- 2022-09-30 AU AU2022450370A patent/AU2022450370A1/en active Pending
- 2022-09-30 US US18/851,844 patent/US20260041742A1/en active Pending
-
2024
- 2024-09-26 MX MX2024011876A patent/MX2024011876A/es unknown
- 2024-10-30 CO CONC2024/0014833A patent/CO2024014833A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3528833B1 (en) | Methods for treating muscle wasting and bone disease using novel hybrid actriib ligand trap proteins | |
| JP2022552371A5 (enExample) | ||
| US10335455B2 (en) | Method for prevention or treatment of intractable inflammatory bowel disease | |
| US6727355B2 (en) | Pharmaceutical composition for treatment of Duchenne muscular dystrophy | |
| CA2145778A1 (en) | Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids | |
| US20170340713A1 (en) | Compositions for Treating Pathological Calcification Conditions, and Methods Using Same | |
| JPH08504763A (ja) | 治療薬としてのＴＧＦ−βレセプターフラグメントの使用 | |
| JP6387392B2 (ja) | 第ｉｘ因子ポリペプチド製剤 | |
| CN101466399B (zh) | 稳定的胰岛素样生长因子多肽 | |
| US11136388B2 (en) | Biomarkers for anti-IL4-IL13 bispecific antibodies | |
| EP3991743A1 (en) | Immune inducer and pharmaceutical composition for preventing or treating aging-related diseases | |
| CN116887868A (zh) | 达农病的治疗 | |
| AU674697B2 (en) | Use of specific binding molecules in potentiating IGF-I activity | |
| US20180099023A1 (en) | Methods of treating iron overload | |
| US7468353B2 (en) | Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung diseases | |
| WO2009133905A1 (ja) | ヒト線維芽細胞増殖因子23（ヒトfgf23)の作用を抑制するペプチドおよびそれを含む医薬組成物 | |
| RU2024129908A (ru) | Способ и композиции для лечения, облегчения и/или предупреждения диффузного идиопатического скелетного гиперостоза (dish) | |
| TW202436620A (zh) | 用於在兒科患者中治療嬰兒型龐貝氏症之方法 | |
| CN121057588A (zh) | 用于在儿科患者中治疗迟发性庞贝病的方法 | |
| JP2024540220A (ja) | Ｄｓｇ２組成物及び方法 | |
| JP3034032B2 (ja) | 腸疾患用薬剤 | |
| EP3493832A1 (en) | Pharmaceutical formulations of c1 esterase inhibitor | |
| JPH0867636A (ja) | 播種性血管内凝固症候群（ｄｉｃ）の予防治療薬 | |
| AU2021377176A1 (en) | Bifunctional antagonists of activin/tgf-beta and rankl and uses thereof | |
| HK40108458A (en) | Antisense oligonucleotides that bind to exon 51 of human dystrophin pre-mrna |